Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Haas

Showing results (111-120 of 171) with videos related to

Pageof 18
Sort By:
Journal of Gastroenterology|February 26, 2013
KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancerStefan Boeck, Andreas Jung, Rüdiger P Laubender, et al.
Angewandte Chemie (International Ed. in English)|August 31, 2021
Isolable Geminal Bisgermenolates: A New Synthon in Organometallic ChemistryManfred Drusgala, Philipp Frühwirt, Gabriel Glotz, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 7, 2023
Symmetrical and Mixed Tris(acyl)phosphines: Synthesis, Oxidation and PhotochemistryTanja Wiesner, Dmytro Neshchadin, Gabriel Glotz, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
Isolable Geminal Bisgermenolates: A New Synthon in Organometallic ChemistryManfred Drusgala, Philipp Frühwirt, Gabriel Glotz, et al.
Oncoimmunology|June 23, 2017
Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancerStephan Kruger, Marie-Louise Legenstein, Verena Rösgen, et al.
Dalton Transactions (Cambridge, England : 2003)|February 7, 2022
Correction: Synthesis and characterization of diacylgermanes: persistent derivatives with superior photoreactivitySabrina D Püschmann, Philipp Frühwirt, Stefanie M Müller, et al.
British Journal of Cancer|June 11, 2021
Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 studyMichael Guenther, Michael Haas, Volker Heinemann, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2014
Human equilibrative nucleoside transporter 1 is not predictive for gemcitabine efficacy in advanced pancreatic cancer: translational results from the AIO-PK0104 phase III study with the clone SP120 rabbit antibodySteffen Ormanns, Volker Heinemann, Mitch Raponi, et al.
British Journal of Cancer|August 25, 2020
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 studyMichael Guenther, Michael Haas, Volker Heinemann, et al.
Angewandte Chemie (International Ed. in English)|April 14, 2020
Electrocatalytic Reduction of CO<sub>2</sub> to Acetic Acid by a Molecular Manganese Corrole ComplexRatnadip De, Sabrina Gonglach, Shounik Paul, et al.
Pageof 18

Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
Journal of Gastroenterology|February 26, 2013
KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancerStefan Boeck, Andreas Jung, Rüdiger P Laubender, et al.
Angewandte Chemie (International Ed. in English)|August 31, 2021
Isolable Geminal Bisgermenolates: A New Synthon in Organometallic ChemistryManfred Drusgala, Philipp Frühwirt, Gabriel Glotz, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 7, 2023
Symmetrical and Mixed Tris(acyl)phosphines: Synthesis, Oxidation and PhotochemistryTanja Wiesner, Dmytro Neshchadin, Gabriel Glotz, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|March 20, 2024
Isolable Geminal Bisgermenolates: A New Synthon in Organometallic ChemistryManfred Drusgala, Philipp Frühwirt, Gabriel Glotz, et al.
Oncoimmunology|June 23, 2017
Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancerStephan Kruger, Marie-Louise Legenstein, Verena Rösgen, et al.
Dalton Transactions (Cambridge, England : 2003)|February 7, 2022
Correction: Synthesis and characterization of diacylgermanes: persistent derivatives with superior photoreactivitySabrina D Püschmann, Philipp Frühwirt, Stefanie M Müller, et al.
British Journal of Cancer|June 11, 2021
Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 studyMichael Guenther, Michael Haas, Volker Heinemann, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2014
Human equilibrative nucleoside transporter 1 is not predictive for gemcitabine efficacy in advanced pancreatic cancer: translational results from the AIO-PK0104 phase III study with the clone SP120 rabbit antibodySteffen Ormanns, Volker Heinemann, Mitch Raponi, et al.
British Journal of Cancer|August 25, 2020
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 studyMichael Guenther, Michael Haas, Volker Heinemann, et al.
Angewandte Chemie (International Ed. in English)|April 14, 2020
Electrocatalytic Reduction of CO<sub>2</sub> to Acetic Acid by a Molecular Manganese Corrole ComplexRatnadip De, Sabrina Gonglach, Shounik Paul, et al.
Pageof 18